Literature DB >> 28356331

DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes.

Luis Gomez-Sarosi1, Yu Sun2, Ilsa Coleman1, Daniella Bianchi-Frias1, Peter S Nelson3,4.   

Abstract

Carcinomas develop in complex environments that include a diverse spectrum of cell types that influence tumor cell behavior. These microenvironments represent dynamic systems that contribute to pathologic processes. Damage to DNA is a notable inducer of both transient and permanent alterations in cellular phenotypes. Induction of a DNA damage secretory program is known to promote adverse tumor cell behaviors such as proliferation, invasion, metastasis, and treatment resistance. However, prior studies designed to identify genotoxic stress-induced factors evaluated actively proliferating in vitro cultures of cells such as fibroblasts as experimental models. Conversely, the vast majority of benign cells in a typical tumor microenvironment (TME) are not proliferating but rather exist in quiescent (i.e., G0) or in terminally differentiated states. In this study, the diversity and magnitude of transcriptional responses to genotoxic damage in quiescent prostate fibroblasts were assessed using gene expression profiling. The secretory damage response in quiescent cells was highly concordant with that of actively dividing cells. Quiescent human prostate stroma exposed to genotoxic agents (e.g., mitoxantrone) in vivo resulted in significant upregulation (2.7- to 5.7-fold; P ≤ 0.01) of growth factors and cytokines including IL1β, MMP3, IL6, and IL8. The paracrine effects of damaged quiescent cells consistently increased the proliferation and invasion of prostate cancer cells and promoted cell survival and resistance to apoptosis following exposure to chemotherapy.Implications: Benign quiescent cells in the TME respond to genotoxic stress by inducing a secretory program capable of promoting therapy resistance. Developing approaches to suppress the secretory program may improve treatment responses. Mol Cancer Res; 15(7); 842-51. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28356331      PMCID: PMC5859576          DOI: 10.1158/1541-7786.MCR-16-0387

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  35 in total

1.  The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.

Authors:  Chanhee Kang; Qikai Xu; Timothy D Martin; Mamie Z Li; Marco Demaria; Liviu Aron; Tao Lu; Bruce A Yankner; Judith Campisi; Stephen J Elledge
Journal:  Science       Date:  2015-09-25       Impact factor: 47.728

2.  Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Authors:  Jack Cuzick; Gregory P Swanson; Gabrielle Fisher; Arthur R Brothman; Daniel M Berney; Julia E Reid; David Mesher; V O Speights; Elzbieta Stankiewicz; Christopher S Foster; Henrik Møller; Peter Scardino; Jorja D Warren; Jimmy Park; Adib Younus; Darl D Flake; Susanne Wagner; Alexander Gutin; Jerry S Lanchbury; Steven Stone
Journal:  Lancet Oncol       Date:  2011-03       Impact factor: 41.316

3.  p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.

Authors:  Adam Freund; Christopher K Patil; Judith Campisi
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

4.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.

Authors:  Remi-Martin Laberge; Yu Sun; Arturo V Orjalo; Christopher K Patil; Adam Freund; Lili Zhou; Samuel C Curran; Albert R Davalos; Kathleen A Wilson-Edell; Su Liu; Chandani Limbad; Marco Demaria; Patrick Li; Gene B Hubbard; Yuji Ikeno; Martin Javors; Pierre-Yves Desprez; Christopher C Benz; Pankaj Kapahi; Peter S Nelson; Judith Campisi
Journal:  Nat Cell Biol       Date:  2015-07-06       Impact factor: 28.824

5.  Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.

Authors:  Yu Sun; Peter S Nelson
Journal:  Clin Cancer Res       Date:  2012-05-22       Impact factor: 12.531

6.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.

Authors:  Claes Bavik; Ilsa Coleman; James P Dean; Beatrice Knudsen; Steven Plymate; Peter S Nelson
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 7.  Microenvironmental regulation of cancer development.

Authors:  Min Hu; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2008-02-20       Impact factor: 5.578

8.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Authors:  Daniella Bianchi-Frias; Funda Vakar-Lopez; Ilsa M Coleman; Stephen R Plymate; May J Reed; Peter S Nelson
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.

Authors:  M S Tretiakova; W Wei; H D Boyer; L F Newcomb; S Hawley; H Auman; F Vakar-Lopez; J K McKenney; L Fazli; J Simko; D A Troyer; A Hurtado-Coll; I M Thompson; P R Carroll; W J Ellis; M E Gleave; P S Nelson; D W Lin; L D True; Z Feng; J D Brooks
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-05-03       Impact factor: 5.554

10.  Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.

Authors:  Jean-Philippe Coppé; Christopher K Patil; Francis Rodier; Yu Sun; Denise P Muñoz; Joshua Goldstein; Peter S Nelson; Pierre-Yves Desprez; Judith Campisi
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

View more
  7 in total

Review 1.  DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives.

Authors:  Öykü Gönül Geyik; Giulia Anichini; Engin Ulukaya; Fabio Marra; Chiara Raggi
Journal:  Cells       Date:  2022-04-26       Impact factor: 7.666

2.  PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.

Authors:  Xiaoting Li; Tian Fang; Sen Xu; Ping Jin; Dongchen Zhou; Zhengzheng Wang; Huayi Li; Zongyuan Yang; Gang Chen; Xu Zheng; Yu Xia; Xiao Wei; Zeyu Zhang; Xin Yang; Ya Wang; Qinglei Gao
Journal:  NPJ Precis Oncol       Date:  2021-06-09

3.  Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer.

Authors:  Sha Zhu; Lili Jiang; Liuyan Wang; Lingli Wang; Cong Zhang; Yu Ma; Tao Huang
Journal:  Cancer Manag Res       Date:  2019-01-03       Impact factor: 3.989

4.  A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression.

Authors:  Xueqi Yan; Yaozhou He; Shikun Yang; Tianyu Zeng; Yijia Hua; Shengnan Bao; Fan Yang; Ningjun Duan; Chunxiao Sun; Yan Liang; Ziyi Fu; Xiang Huang; Wei Li; Yongmei Yin
Journal:  Cell Death Discov       Date:  2022-04-12

Review 5.  Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells.

Authors:  Taja Železnik Ramuta; Mateja Erdani Kreft
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

6.  Transcriptome analysis of differentially expressed genes and pathways associated with mitoxantrone treatment prostate cancer.

Authors:  Sanqiang Li; Ruifang Li; Yu Ma; Cong Zhang; Tao Huang; Sha Zhu
Journal:  J Cell Mol Med       Date:  2018-12-27       Impact factor: 5.310

7.  EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization.

Authors:  Bo Zhang; Tianyu Miao; Xin Shen; Lirong Bao; Cheng Zhang; Caixia Yan; Wei Wei; Jiao Chen; Liying Xiao; Chongkui Sun; Jintao Du; Yan Li
Journal:  Cell Death Dis       Date:  2020-09-11       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.